(Q46803480)

English

An open-label, multicentre, randomized, crossover study comparing sildenafil citrate and tadalafil for treating erectile dysfunction in men naïve to phosphodiesterase 5 inhibitor therapy

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16287454

An open-label, multicentre, randomized, crossover study comparing sildenafil citrate and tadalafil for treating erectile dysfunction in men naïve to phosphodiesterase 5 inhibitor therapy (English)

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16287454

erectile dysfunction

1 reference

based on heuristic

inferred from title

Francesco Montorsi

3

object named as

Francesco Montorsi

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16287454

author name string

Ian Eardley

1

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16287454

Vincenzo Mirone

2

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16287454

David Ralph

4

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16287454

Philip Kell

5

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16287454

Margaret R Warner

6

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16287454

Yanli Zhao

7

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16287454

Anthony Beardsworth

8

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16287454

publication date

1 December 2005

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16287454

BJU International

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16287454

96

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16287454

9

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16287454

1323-1332

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16287454

Male erectile dysfunction and health-related quality of life.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.05892.X

21 January 2018

On life satisfaction in male erectile dysfunction.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.05892.X

21 January 2018

Oral sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.05892.X

21 January 2018

Efficacy and safety of tadalafil for the treatment of erectile dysfunction: results of integrated analyses

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.05892.X

21 January 2018

Erectile dysfunction

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.05892.X

21 January 2018

Sustained efficacy and tolerability with vardenafil over 2 years of treatment in men with erectile dysfunction

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.05892.X

21 January 2018

The efficacy and safety of tadalafil: an update

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.05892.X

21 January 2018

Impact of diabetes mellitus on the severity of erectile dysfunction and response to treatment: analysis of data from tadalafil clinical trials

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.05892.X

21 January 2018

Sildenafil citrate after radical retropubic prostatectomy.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.05892.X

21 January 2018

Time/duration effectiveness of sildenafil versus tadalafil in the treatment of erectile dysfunction in male spinal cord-injured patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.05892.X

21 January 2018

Cardiovascular effects of tadalafil in patients on common antihypertensive therapies

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.05892.X

21 January 2018

Tadalafil in the treatment of erectile dysfunction following bilateral nerve sparing radical retropubic prostatectomy: a randomized, double-blind, placebo controlled trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.05892.X

21 January 2018

Sildenafil for treatment of erectile dysfunction in men with diabetes: a randomized controlled trial. Sildenafil Diabetes Study Group.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.05892.X

21 January 2018

The multinational Men's Attitudes to Life Events and Sexuality (MALES) Study Phase II: understanding PDE5 inhibitor treatment seeking patterns, among men with erectile dysfunction

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.05892.X

21 January 2018

The 'effectiveness' scale--therapeutic outcome of pharmacologic therapies for ED: an international consensus panel report

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.05892.X

21 January 2018

Patient and partner satisfaction with Viagra (sildenafil citrate) treatment as determined by the Erectile Dysfunction Inventory of Treatment Satisfaction Questionnaire

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.05892.X

21 January 2018

A multicenter, randomized, double-blind, crossover study of patient preference for tadalafil 20 mg or sildenafil citrate 50 mg during initiation of treatment for erectile dysfunction

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.05892.X

21 January 2018

A multicenter, randomized, double-blind, crossover study to evaluate patient preference between tadalafil and sildenafil

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.05892.X

21 January 2018

Switching patients with erectile dysfunction from sildenafil citrate to tadalafil: results of a European multicenter, open-label study of patient preference

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.05892.X

21 January 2018

Diagnostic evaluation of the erectile function domain of the International Index of Erectile Function.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.05892.X

21 January 2018

The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.05892.X

21 January 2018

An open-label, randomized, flexible-dose, crossover study to assess the comparative efficacy and safety of sildenafil citrate and apomorphine hydrochloride in men with erectile dysfunction

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.05892.X

21 January 2018

Long-term safety and tolerability of tadalafil in the treatment of erectile dysfunction

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.05892.X

21 January 2018

Understanding erectile dysfunction medication preference studies

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.05892.X

21 January 2018

Identifiers

10.1111/J.1464-410X.2005.05892.X

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16287454

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16287454

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46803480&oldid=2132825802"